Aradigm Launches First-of-Its-Kind Platform to Provide Sustainable Access to Life-Saving Cell and Gene Therapies
Aradigm Launches First-of-Its-Kind Platform to Provide Sustainable Access to Life-Saving Cell and Gene Therapies Company Closes $20 Million Series A Led by Frist Cressey Ventures and backed by Morgan Health and Andreessen Horowitz GlobeNewswire December 09, 2025 NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — Aradigm, a benefits platform for cell and gene therapies, launched […]